Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Equity Ratio: 2021-2024

Historic Equity Ratio for Kiniksa Pharmaceuticals International (KNSA) over the last 4 years, with Dec 2024 value amounting to 0.76.

  • Kiniksa Pharmaceuticals International's Equity Ratio fell 4.50% to 0.75 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.75, marking a year-over-year decrease of 4.50%. This contributed to the annual value of 0.76 for FY2024, which is 9.42% down from last year.
  • As of FY2024, Kiniksa Pharmaceuticals International's Equity Ratio stood at 0.76, which was down 9.42% from 0.83 recorded in FY2023.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Equity Ratio registered a high of 0.86 during FY2022, and its lowest value of 0.76 during FY2024.
  • Over the past 3 years, Kiniksa Pharmaceuticals International's median Equity Ratio value was 0.83 (recorded in 2023), while the average stood at 0.82.
  • In the last 5 years, Kiniksa Pharmaceuticals International's Equity Ratio increased by 8.43% in 2022 and then dropped by 9.42% in 2024.
  • Over the past 4 years, Kiniksa Pharmaceuticals International's Equity Ratio (Yearly) stood at 0.79 in 2021, then increased by 8.43% to 0.86 in 2022, then declined by 3.25% to 0.83 in 2023, then declined by 9.42% to 0.76 in 2024.